Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Phase II Study of the Bortezomib-Melphalan-Prednisolone Induction Therapy Followed By Lenalidomide-Plus-Dexamethasone Consolidation and Lenalidomide Maintenance in Non-Transplant Eligible Patients with Newly Diagnosed Symptomatic Multiple Myeloma (CANDLE trial)

Blood (2017) 130 (Supplement 1): 3121.

https://doi.org/10.1182/blood.V130.Suppl_1.3121.3121

Published: 2017

Journal Articles

Elotuzumab Plus Lenalidomide/Dexamethasone (ELd) Vs Ld in Patients with Newly Diagnosed Multiple Myeloma: Phase 2, Randomized, Open-Label Study in Japan

Naoki Takezako, MD PhD, Kensuke Ohta, MD PhD, Hiroshi Handa, MD PhDChief Division, Mitsuo Hori, MD PhD, Gen Kinoshita, Suresh Shelat, Masafumi Miyoshi, Kohmei Kubo

Blood (2017) 130 (Supplement 1): 434.

https://doi.org/10.1182/blood.V130.Suppl_1.434.434

Published: 2017

Journal Articles

Combination of Frailty Status and Comorbidity Score Improves the Prediction of Survival in Patients with Myelodysplastic Syndrome Due to Good Predictive Capability for Infection-Related Mortality

Kazuki Sakatoku, MD, Yasunobu Takeoka, MD, PhD, Taku Araki, MD, Ryosuke Yamamura, MD, PhD, Takahiko Nakane, MD, PhD, Hirohisa Nakamae, MD PhD, Masayuki Hino, MD, PhD, Kensuke Ohta, MD, PhD

Blood (2016) 128 (22): 1995.

https://doi.org/10.1182/blood.V128.22.1995.1995

Published: 2016

Journal Articles

A Detailed Analysis of Myelodysplastic Syndrome Complicated By Autoimmune or Inflammatory Disorders: A Possible Efficacy of Low-Dose Lenalidomide

Yasunobu Takeoka, Akiko Miura, Koji Nakamura, Junko Nakamura, Ryosuke Yamamura, MD PhD, Taku Araki, Hirohisa Nakamae, Masayuki Hino, Prof., Kensuke Ohta, MD PhD

Blood (2014) 124 (21): 3256.

https://doi.org/10.1182/blood.V124.21.3256.3256

Published: 2014

Journal Articles

Retrospective Analysis Of The Recent Treatment Strategies For The Patients With Myeloma-Related Diseases Registered In Kansai Myeloma Forum

Blood (2013) 122 (21): 3385.

https://doi.org/10.1182/blood.V122.21.3385.3385

Published: 2013

Journal Articles

The Diagnostic and Prognostic Utility of 18F-FDG PET/CT in Transplant Ineligible Multiple Myeloma Patients Receiving Novel Agents

Yasunobu Takeoka, Ryosuke Yamamura, MD, PhD, Taku Araki, Akiko Inaba, Yotaro Fujitani, Genju Koh, Hirotaka Seura, Terue Okamura, Kensuke Ohta, MD, PhD

Blood (2013) 122 (21): 1883.

https://doi.org/10.1182/blood.V122.21.1883.1883

Published: 2013

Journal Articles

The Impact of Relative Dose Intensity of Rituximab-CHOP on Survival in Diffuse Large B-Cell Lymphoma Patients

Yoshiki Terada, MD, PhD, Hirohisa Nakamae, MD, PhD, Ran Moriguchi, MD, Hiroshi Kanashima, MD, PhD, Erina Sakamoto, MD, PhD, Dai Momose, MD, Mizuki Aimoto, MD, Shuichirou Okamoto, MD, Eri Wada, MD, Hideo Koh, MD, Takahiko Nakane, MD, Yasunobu Takeoka, MD, Ki- Ryang Koh, MD, PhD, Takahisa Yamane, MD, PhD, Yoshitaka Nakao, MD, PhD, Kensuke Ohta, MD, PhD, Atsuko Mugitani, MD, PhD, Hirofumi Teshima, MD, PhD, Masayuki Hino, MD, PhD

Blood (2008) 112 (11): 4931.

https://doi.org/10.1182/blood.V112.11.4931.4931

Published: 2008

Journal Articles

Possible Involvement of γδ-T Cells in the Development of Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

Ki-Ryang Koh, MD, PhD, Hirohisa Nakamae, M.D., Ph.D., Kensuke Ohta, M.D., Ph.D., Hongzhang Li, M.D., Hideo Koh, M.D., Takahiko Nakane, M.D., Yasunobu Takeoka, M.D., Asao Hirose, M.D., Ph.D., Kiyoyuki Hagihara, M.D., Ph.D., Erina Sakamoto, M.D., Ph.D., Mika Nakamae, M.D., Ph.D., Yoshiki Terada, M.D., Ph.D., Takahisa Yamane, M.D., Ph.D., Masayuki Hino, M.D., Ph.D.

Blood (2007) 110 (11): 1971.

https://doi.org/10.1182/blood.V110.11.1971.1971

Published: 2007

Journal Articles

The Impact of Relative Dose Intensity (RDI) of CHOP on Outcome of Diffuse Large B-Cell Lymphoma: Results of a Single Center Study.

Yoshiki Terada, MD, PhD, Hirohisa Nakamae, M.D., Ph.D., Takahiko Nakane, M.D., Hideo Koh, M.D., Yasunobu Takeoka, M.D., Ran Moriguchi, M.D., Mizuki Aimoto, M.D., Yuki Akazawa, M.D., Eri Wada, M.D., Hiroshi Kanashima, M.D., Ph.D., Erina Sakamoto, M.D., Ph.D., Ki-Ryang Koh, M.D., Ph.D., Takahisa Yamane, M.D., Ph.D., Kensuke Ohta, M.D., Ph.D., Yoshitaka Nakao, M.D., Ph.D., Hirofumi Teshima, M.D., Ph.D., Masayuki Hino, M.D., Ph.D.

Blood (2007) 110 (11): 4456.

https://doi.org/10.1182/blood.V110.11.4456.4456

Published: 2007

Journal Articles

Preferential Th2 Polarization at the Onset of Thrombotic Microangiopathy (TMA): Immunological Comparison of TMA Versus Acute GVHD in Terms of Peripheral T Cell Subsets, Dendritic Cell Subsets and Cytokine Profiles.

Ki-Ryang Koh, MD, PhD, Hirohisa Nakamae, M.D., Ph. D., Kensuke Ohta, M.D., Ph. D., Hideo Koh, M.D., Takahiko Nakane, M.D., Mika Nakamae, M.D., Ph. D., Hiroshi Kanashima, M.D., Ph. D., Kiyoyuki Hagihara, M.D., Ph. D., Erina Sakamoto, M.D., Ph. D., Yoshiki Terada, M.D., Ph. D., Yasunobu Takeoka, M.D., Asao Hirose, M.D., Ph. D., Takahisa Yamane, M.D., Ph. D., Masayuki Hino, M.D., Ph.D

Blood (2006) 108 (11): 2885.

https://doi.org/10.1182/blood.V108.11.2885.2885

Published: 2006

Journal Articles

Risk Factor Analysis for Thrombotic Microangiopathy after Reduced Intensity or Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation.

Hirohisa Nakamae, MD, PhD, Takahisa Yamane, MD, PhD, Hagihara Kiyoyuki, MD., PhD., Yasunobu Takeoka, MD., Erina Sakamoto, MD., PhD., Takahiko Nakane, MD., Mika Nakamae, MD., PhD., Ki-Ryang Koh, MD., PhD., Kensuke Ohta, MD., PhD., Masayuki Hino, MD., PhD.

Blood (2005) 106 (11): 1775.

https://doi.org/10.1182/blood.V106.11.1775.1775

Published: 2005

Journal Articles

Significant and Morbid Changes in Heart Rate Variability Precedes and Complicates Symptomatic Hypotension in Peripheral Blood Stem Cell Apheresis.

Hirohisa Nakamae, M.D., Ph.D., Yoshiki Terada, M.D., Ph.D., Mika Akahori, M.D., Takahiko Nakane, M.D., Kiyoyuki Hagihara, M.D., Yasunobu Takeoka, M.D., Taro Hasegawa, M.D., Ph.D., Kensuke Ohta, M.D., Ph.D., Takahisa Yamane, M.D., Ph.D., Masayuki Hino, M.D., Ph.D.

Blood (2004) 104 (11): 4996.

https://doi.org/10.1182/blood.V104.11.4996.4996

Published: 2004

Journal Articles

Stimulation of the Supportive Function of Marrow Stromal Cells by Anticancer Agents: Critical Role of Marrow Macrophages.

Kensuke Ohta, M.D., Hirohisa Nakamae, M.D., Ki-Ryang Koh, M.D., Kiyotaka Nakaie, Hong-Zhang Li, Takahisa Yamane, M.D., Takayuki Takubo, M.D., Masayuki Hino, M.D.

Blood (2004) 104 (11): 4252.

https://doi.org/10.1182/blood.V104.11.4252.4252

Published: 2004

Journal Articles

Expression of the inhibitor of apoptosis (IAP) family members in human neutrophils: up-regulation of cIAP2 by granulocyte colony-stimulating factor and overexpression of cIAP2 in chronic neutrophilic leukemia

Taro Hasegawa, Kenichi Suzuki, Chikahiko Sakamoto, Kensuke Ohta, Saori Nishiki, Masayuki Hino, Noriyuki Tatsumi, Seiichi Kitagawa

Blood (2003) 101 (3): 1164–1171.

https://doi.org/10.1182/blood-2002-05-1505

Published: 2003

NARROW

Phase II Study of the Bortezomib-Melphalan-Prednisolone Induction Therapy Followed By Lenalidomide-Plus-Dexamethasone Consolidation and Lenalidomide Maintenance in Non-Transplant Eligible Patients with Newly Diagnosed Symptomatic Multiple Myeloma (CANDLE trial)

Elotuzumab Plus Lenalidomide/Dexamethasone (ELd) Vs Ld in Patients with Newly Diagnosed Multiple Myeloma: Phase 2, Randomized, Open-Label Study in Japan

Combination of Frailty Status and Comorbidity Score Improves the Prediction of Survival in Patients with Myelodysplastic Syndrome Due to Good Predictive Capability for Infection-Related Mortality

A Detailed Analysis of Myelodysplastic Syndrome Complicated By Autoimmune or Inflammatory Disorders: A Possible Efficacy of Low-Dose Lenalidomide

Retrospective Analysis Of The Recent Treatment Strategies For The Patients With Myeloma-Related Diseases Registered In Kansai Myeloma Forum

The Diagnostic and Prognostic Utility of 18F-FDG PET/CT in Transplant Ineligible Multiple Myeloma Patients Receiving Novel Agents

The Impact of Relative Dose Intensity of Rituximab-CHOP on Survival in Diffuse Large B-Cell Lymphoma Patients

Possible Involvement of γδ-T Cells in the Development of Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

The Impact of Relative Dose Intensity (RDI) of CHOP on Outcome of Diffuse Large B-Cell Lymphoma: Results of a Single Center Study.

Preferential Th2 Polarization at the Onset of Thrombotic Microangiopathy (TMA): Immunological Comparison of TMA Versus Acute GVHD in Terms of Peripheral T Cell Subsets, Dendritic Cell Subsets and Cytokine Profiles.

Risk Factor Analysis for Thrombotic Microangiopathy after Reduced Intensity or Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation.

Significant and Morbid Changes in Heart Rate Variability Precedes and Complicates Symptomatic Hypotension in Peripheral Blood Stem Cell Apheresis.

Stimulation of the Supportive Function of Marrow Stromal Cells by Anticancer Agents: Critical Role of Marrow Macrophages.

Expression of the inhibitor of apoptosis (IAP) family members in human neutrophils: up-regulation of cIAP2 by granulocyte colony-stimulating factor and overexpression of cIAP2 in chronic neutrophilic leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only